EyePoint (EYPT) EBITDA Margin (2010 - 2026)
EyePoint (EYPT) posted EBITDA Margin of -19071.01% for Q2 2026, down 17914.26 percentage points from -1156.74% a year earlier and down 6629.91 percentage points from the prior quarter.
EyePoint (EYPT) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at EyePoint was -11279.49%, down 10918.90 percentage points year-over-year; for FY2025, it was -768.62%, down 435.13 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -668.15 percentage points (FY2020 to FY2025).
- In prior years, EyePoint's EBITDA Margin was -333.50% in FY2024 (-171.46 pp), -162.04% in FY2023 (+72.69 pp), -234.73% in FY2022 (-92.70 pp) and -142.03% in FY2021 (-41.56 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin in data going back to Q4 2018.
- On a year-over-year basis, EBITDA Margin has declined in each of the last five quarters, with an average year-over-year change of -6035.95 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2023, with a gain of 296.47 percentage points; the weakest was Q2 2026, with a drop of 17914.26 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -12441.09% (Q1 2026), -11267.10% (Q4 2025) and -6361.18% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | EyePoint | 281.29 Mn | -631.84 Mn | 507,000.00 | -19,071.01% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19,071.01% |
| Mar 31, 2026 | -12,441.09% |
| Dec 31, 2025 | -11,267.10% |
| Sep 30, 2025 | -6,361.18% |
| Jun 30, 2025 | -1,156.74% |
| Mar 31, 2025 | -197.69% |
| Dec 31, 2024 | -386.37% |
| Sep 30, 2024 | -307.30% |
| Jun 30, 2024 | -360.70% |
| Mar 31, 2024 | -282.59% |
| Dec 31, 2023 | -115.53% |
| Sep 30, 2023 | -93.95% |
| Jun 30, 2023 | -248.53% |
| Mar 31, 2023 | -279.17% |
| Dec 31, 2022 | -412.00% |
| Sep 30, 2022 | -176.66% |
| Jun 30, 2022 | -160.07% |
| Mar 31, 2022 | -189.24% |
| Dec 31, 2021 | -149.97% |
| Sep 30, 2021 | -161.30% |
EyePoint EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EYPT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();